NCT01268046

Aging and Estrogen on Cortical Function

The Effect of Low Dose Estrogen on Cortical Function as a Function of Age in Postmenopausal Women.

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: Massachusetts General Hospital · Academic / Other
• Sex: Female
• Age: 45 Years – 80 Years
• Healthy volunteers: Accepted

Summary

This study will focus on how estrogen affects parts of the brain associated with memory and how the effect of estrogen is altered with aging in postmenopausal women.

Detailed description

The broad goal of this proposal is to determine the effect of aging on areas of the brain whose function is impacted by gonadal steroids in women. The overarching hypothesis is that aging differentially alters the effects of estrogen on the brain. Our preliminary data indicated that aging alters the effect of estrogen on brain regions involved in cognition and thus, the current study focused on the impact of aging on functional changes induced by estrogen in cortical and subcortical areas associated with verbal working memory and declarative/episodic memory. As our model, we will use women in whom the absence of gonadal function makes it possible to control the duration and amount of estrogen exposure, specifically postmenopausal women who are younger (45-55) or older (65-80) who receive either oral or transdermal estradiol to achieve premenopausal early follicular phase estradiol levels.. We evaluate the effects of low dose estrogen exposure at 48 hr and 1 month to determine whether the short-term changes in brain regions involved in cognition with low dose estrogen exposure seen in our preliminary studies are confirmed and whether changes with short-term estrogen exposure persist with more prolonged exposure, a finding that would have enormous clinical relevance. These studies, using sophisticated neuroimaging tools (structural and functional magnetic resonance imaging \[MRI\] and \[18F\] 2-fluoro-2-deoxy-D-glucose positron emission tomography \[FDG-PET\]), provide a unique window into the brain in women.

Conditions

• Memory Loss
• Cognitive Changes
• Postmenopausal Symptoms

Interventions

Type	Name	Description
DRUG	Estradiol oral capsule	1 oral capsule (1 mg estradiol) administered daily for one month
DRUG	transderman estrogen patch	transdermal estrogen patch (50 mcg/day) for one month
DRUG	trasdermal placebo patch	transdermal placebo patch with patch change every 84 hr for one month
DRUG	placebo oral capsule	placebo oral capsule administered daily for one month.

Timeline

• Start date: 2009-11-01
• Primary completion: 2013-12-02
• Completion: 2013-12-02
• First posted: 2010-12-29
• Last updated: 2018-08-22
• Results posted: 2018-08-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study